Various strains of black-pigmented Bacteroides species were grown on horse blood agar and suspended in human serum. After various times of incubation the effect of the bacteria on the serum was evaluated by polyacrylamide gel electrophoresis and "rocket" immunoelectrophoresis. The formation of trichloroacetic acid-soluble material in the suspensions and the capacity of the treated sera to inhibit the activity of trypsin were also determined. The two tested strains of Bacteroides gingivalis (W83, H185) degraded most serum proteins, including the plasma proteinase inhibitors alpha-1-antitrypsin and alpha-2-macroglobulin. They did not, however, degrade alpha-1-antichymotrypsin. Bacteroides intermedius NCTC 9336, Bacteroides asaccharolyticus NCTC 9337, and an asaccharolytic oral strain different from B. gingivalis (BN11a-f) did not degrade the plasma proteinase inhibitors. These strains were, however, able to inactivate the capacity of serum to inhibit the activity of trypsin.
Polymorphonuclear leukocytes play an important role in the host defense against tissue-invading bacteria. In addition to phagocytosis and killing of the bacteria, the leukocytes release large amounts of tissue-degrading enzymes, which facilitate the host defense by demarcating the infected site. An abscess cavity is formed and drained by the action of the leukocyte enzymes. The degradation of the tissue components collagen, elastin, and proteoglycans is the result of the concerted action of a number of leukocyte proteinases (25) . The leukocytes harbor not only the serine proteinases elastase (10) cathepsin G (29) and a collagenolytic neutral proteinase (27) , but also the metalloenzyme collagenase (17, 22) . To preserve the integrity of the tissues surrounding the site of infection and actually the site of leukocyte enzyme release, the activities of these enzymes are modulated by proteinase inhibitors present in high concentrations in the body fluids (8) .
The main inhibitors of the leukocyte proteinases are alpha-1-antitrypsin, alpha-1-antichymotrypsin, and alpha-2-macroglobulin. Alpha-1-antitrypsin is quantitatively dominating and is specific for serine proteinases (11) . Alpha-1-antichymotrypsin is a potent inhibitor of cathepsin G (26) . Alpha-2-macroglobulin may inhibit proteinases of different types (32) . These proteinase inhibitors have an effect not only on tissue enzymes, but also on several microbial proteinases (11, 32) . The role of proteinase inhibitors in preventing tissue injury is demonstrated in pulmonary emphysema, where congenital deficiency of alpha-1-antitrypsin is associated with early onset of the disease (16) .
A strain of Bacteroides gingivalis (W83) induces in guinea pigs purulent infections that spread rapidly and result in extensive necrotic breakdown of the tissues (12; G. K. (35) . The ability to degrade proteinase inhibitors in vitro has also been reported for strains of Proteus mirabilis and Pseudomonas aeruginosa (20, 21) and would certainly be of utmost importance for the outcome of the host-microbe interactions in vivo. We now report that strains of B. gingivalis were able to degrade the human plasma proteinase inhibitors alpha-iantitrypsin and alpha-2-macroglobulin, but not alpha-i-antichymotrypsin.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Two strains of B. gingivalis (W83, H185) were obtained from T. J. M. van Steenbergen, The Netherlands. B. asaccharolyticus NCTC 9337 and Bacteroides intermedius NCTC 9336 were from National Collection of Type Cultures, Colindale, England. Strain BNlla-f was an oral black-pigtnented asaccharolytic Bacteroides sp. with a DNA composition different from that of B. gingivalis (34) . All strains were kept on blood agar plates in an anaerobic box with an atmosphere of 5% carbon dioxide and 10% hydrogen in nitrogen. The blood agar medium was prepared as described by Holdeman and collaborators (9) . The defibrinated horse blood in this medium was hemolyzed by freeze-thawing. The bacteria were suspended in morpholinepropanesulfonic acid (MOPS) dilution solution, which was a modification of a medium devised by Neidhardt and collaborators (23) and contained 40 mM 3-N-MOPS, 4 from the surface of blood agar after cultivation for 2 to 5 days, depending on the growth rate of the actual strain. The reaction mixture was incubated at 37°C, and 0.1-ml samples were taken at regular time intervals and added to 0.4 ml of 0.25 M trichloroacetic acid. After the precipitated proteins had been removed by centrifugation, the extinction of the supernatant fluid was read at 280 nm. As a standard 1 mM Ltyrosine in 0.25 M trichloroacetic acid was used. The numbers of CFU in the bacteria-serum mixtures were also determined. At zero time and after 1, 2, and 6 days, samples were taken from the mixtures, serially diluted, and cultured on blood agar under anaerobic conditions.
The proteolytic activity as disclosed by hydrolysis of benzoyl-D,L-arginine-p-nitranilide was tested at 28°C in a reaction mixture containing 0.73 mM benzoyl-D,L-argininep-nitranilide (Boehringer Mannheim GmbH, Mannheim, West Germany), 12 mM calcium chloride, and bacteria in MOPS dilution solution. After the bacteria had been sedimented by centrifugation, the extinction of the supernatant fluid was read at 410 nm, and the rate of substrate hydrolysis was calculated by assuming an extinction coefficient of 8,800 liters molF cm-' for p-nitranilide at pH 7.0 (4).
Electrophoresis. The bacteria-treated sera were also subjected to analysis of alpha-1-antichymotrypsin, alpha-i-antitrypsin, and alpha-2-macroglobulin by "rocket" immunoelectrophoresis as described by Laurell (15) . Before electrophoresis the bacterial cells were separated from the sera by centrifugation and appropriately diluted. Samples (5 pul) of the sera were applied into 2.5-mm wells in a 1% agarose gel (HSA; Litex, Glostrup, Denmark) in Tris-barbital buffer (pH 8.6). The electrophoresis was carried out at 10 V cm-' for 4 h with the same buffer. After the electrophoresis the agarose gel was washed with 0.85% sodium chloride solution to remove excess protein and was stained with 0.1% Coomassie brilliant blue G-250 (Serva Feinbiochemica, Heidelberg, West Germany) in 50% ethanol-10% acetic acid in water. For destaining 50% ethanol-10% acetic acid in water was used. The antisera were commercial products raised against alpha-1-antitrypsin, alpha-2-macroglobulin, and alpha-1-antichymotrypsin (Dakopatts A/S, Copenhagen, Denmark).
Proteins in bacteria-treated sera were also separated by polyacrylamide gradient gel electrophoresis (Pharmacia Fine Chemicals, Uppsala, Sweden). The gradient gel slabs contained 4 to 30% polyacrylamide, and electrophoresis was run in a Tris buffer (pH 8.4) containing 90 mM Tris, 80 mM boric acid, and 2.5 mM EDTA. The samples were prepared by mixing 25 ,ul of the cell-free fluid, 10 ,u of a 40% sucrose solution, and 0.5 RI of a 1% solution of bromophenol blue in ethanol. A 3-pI sample of this mixture was applied onto the gel, and the electrophoresis was run at 4°C for 24 h at 120 V. After the run the proteins were fixed by treating the gel slab in 150 ml of a 10% sulfosalisylic acid solution for 30 min and stained by submerging the gel for 24 h at room temperature in a solution containing 0.1% Coomassie brillant blue G-250, 25% methanol, and 10% acetic acid in water. The gel was destained by treatment with a solution of 25% methanol and 10% acetic acid in water.
Assay of proteinase inhibitor activity. The capacity of the proteinase inhibitors of the sera to inhibit the activity of trypsin was determined as described by Fritz and collaborators (4 (Fig. 2) . The rate of degradation of the prc into trichloroacetic acid-soluble material was proportior the number of bacteria added to serum (Fig. 3) (Fig. 4) and alpha-2-macroglobulin also (Fig. 5) . It did not degrade, however, the proteinase inhibitor 1, 109 alpha-1-antichymotrypsin (Fig. 6) . The capacity of the serum iuton proteinase inhibitors to inhibit the activity of trypsin was lost ected within 8 h in serum incubated with strain W83 (Fig. 7) . The tivity other strain of B. gingivalis, H185, had similar characteristo a tics ( Fig. 1 and 3 through 7) . (Fig. 4 through 6) . The capacity of the serum proteinase inhibitors to inactivate trypsin was, however, completely abolished by incubating serum for 2 days with strain NCTC 9337 and for 6 days with strain NCTC 9336 (Fig. 7) . Strain BNlla-f also inactivated the serum proteinase inhibitors within a week (Fig. 7) . Fig. 1 . The gels contained antibodies against alpha-1-antitrypsin. As control two parts of human serum was mixed with one part of MOPS dilution solution (S) and incubated under the same conditions as the serum-bacterial suspensions. Before electrophoresis all sera were diluted 1:11 in Tris-barbital buffer (pH 8.6). Symbols: S untreated (1) and further diluted 1:1 in Tris-barbital buffer (8.6), (2); S incubated for 2 days (3) and diluted 1:1 (4), for 6 days (5) and diluted 1:1 (6); sera incubated with bacteria for 1 min (7), 2 h (8), 4 h (9), 8 h (10), 1 day (11), 2 days (12), and 6 days (13). was diluted to give a 70% inhibition of the trypsin activity. The bacteria-treated sera were diluted to the same extent, and their capacities to inhibit trypsin activity were determined.
IOPS
In the suspensions of the various strains in serum the number of CFU increased two-to threefold within 1 day. After 2 days the number of CFU of strain NCTC 9337 had further increased, whereas the number of all the other strains had decreased. After 6 days, less than 1% of the initial CFU could be recovered from the suspensions.
DISCUSSION
Proteinase inhibitors of the mammalian tissue fluids may contribute to the host defense against invasive pathogenic microorganisms by inhibiting the microbial proteolytic enzymes (11, 32) . One of the major functions of the plasma proteinase inhibitors is, however, to modulate the activity of proteinases released by the polymorphonuclear leukocytes involved in the host defense against the microbes (32) . A microorganism with the capacity to produce proteolytic enzymes and to degrade the proteinase inhibitors of the tissue fluids would certainly be predicted to have devastating effects on the tissues of the infected host. The two strains of B. gingivalis of the present study degraded the plasma proteinase inhibitors alpha-1-antitrypsin and alpha-2-macroglobulin. This is of great interest since B. gingivalis has been specifically implicated in the pathogenesis of the advancing lesions of periodontal disease in humans, and this organism usually makes up 20 to 30% of the cultivable microbiota of the deep gingival pockets (31) . This disease is characterized by massive accumulation of polymorphonuclear leukocytes and by breakdown of the periodontal tissues (2). The proteinase inhibitors alpha-1-antitrypsin and alpha-2-macroglobulin, which account for most of the total proteinaseinhibiting capacity of plasma (8) , may play important roles in demarcating the effect of tissue-degrading enzymes released by polymorphonuclear leukocytes into the infected sites (1, 3, 28 (35) cultured the strain on the surface of a medium containing human plasma and analyzed the composition of the medium after 7 and 14 days. We cultured this strain for 3 days on horse blood agar before we suspended it in MOPS dilution solution and mixed one part of the suspension with two parts of human serum. We analyzed the composition of the bacteria-serum mixture after 6 days. It is possible that strain NCTC 9337 is able to induce an enzyme that degrades alpha-1-antitrypsin when growing on human plasma-containing medium, but not when suspended in serum. Further studies have to establish whether this strain or some of the others might acquire the capacity to degrade plasma proteinase inhibitors when growing on a medium containing human plasma. In our study, strain NCTC 9337 inactivated, however, the capacity of serum to inhibit the activity of trypsin and had some effect on alpha-2-macroglobulin, as disclosed by a changed shape of the "rockets" after sera had been incubated with this strain for 2 or 6 days (Fig. 5) .
There was a 24-h lag period before high proteolytic activity was demonstrated in strain NCTC 9337. It is not possible from the present results to decide whether this was due to an initial inhibition of the microbial proteinases by the proteinase inhibitors of the serum, or whether there was a lag period before potent proteinases were induced by this strain. A third possibility would be a condition similar to what has been found with a purified proteinase from Bacteroides amylophilus. When that enzyme was incubated with proteins, a lag period of up to 6 h was observed before the proteins were degraded into trichloroacetic acid-soluble material (18) .
The enzymes that degraded the plasma protein inhibitors might be the same enzymes that split N-benzoyl-D,L-arginine-2-naphtylamide in the API ZYM test (14, 30) . These enzymes have been demonstrated in B. gingivalis, but not in any other human black-pigmented Bacteroides species.
There may, however, be various forms of proteinases among the black-pigmented Bacteroides species. Not only gelatin but also collagen, immunoglobulins A and G, and fibrin can be degraded by various strains of these species (6, 13, 19, 24, 33) . In the present study the polyacrylamide gradient gel electrophoresis of bacteria-treated sera showed that all tested strains had various capacities in degrading various serum proteins. Very little is known, however, about these proteinases. The collagenolytic activity seems to be associated with the cell envelope (7, 19) 
